Standardization of Collected Biobank Data to Facilitate Cardiovascular Research
Updated: October 19, 2026
- Cardiovascular biobanks are essential infrastructure for precision medicine, enabling the discovery of disease mechanisms, biomarkers, and precision therapies. This scientific statement outlines best practices for cardiovascular biobanking and highlights the importance of standardized, interoperable data and biospecimen resources to advance research and patient care.
- Lack of standardization remains a major limitation in biobanking. Standardization of data collection, phenotype definitions, biospecimen handling, and consent practices are necessary to maximize scientific value and enable cross-study collaboration.
- The value of biospecimens can be significantly enhanced when linked to deep longitudinal clinical, imaging, genomic, and outcomes data, enabling more comprehensive investigation of disease mechanisms and clinical trajectories.
Recommended Reading
- Interpreting Incidentally Identified Variants in Genes Associated With Heritable Cardiovascular Disease
- Future Perspectives of Cardiovascular Biomarker Utilization in Cancer Survivors
- Noncoding RNAs in Cardiovascular Disease: Current Knowledge, Tools and Technologies for Investigation and Future Directions
- Genetic Testing for Heritable Cardiovascular Diseases in Pediatric Patients